Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions

HF Kao, PJ Lou - Head & neck, 2019 - Wiley Online Library
Abstract Background Immune checkpoint inhibitors (ICIs) can reinvigorate T cells and
activate the immune system to eliminate cancer cells. Head and neck squamous cell …
被引用次数：54 相关文章

Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions.

HF Kao, PJ Lou - Head & Neck, 2019 - europepmc.org
BACKGROUND: Immune checkpoint inhibitors (ICIs) can reinvigorate T cells and activate
the immune system to eliminate cancer cells. Head and neck squamous cell carcinoma …

Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions

HF Kao, PJ Lou - Head & Neck, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Immune checkpoint inhibitors (ICIs) can reinvigorate T cells and activate the immune system …

Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions

HF Kao, PJ Lou - Head & neck, 2019 - pubmed.ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICIs) can reinvigorate T cells and activate the
immune system to eliminate cancer cells. Head and neck squamous cell carcinoma …

Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions.

HF Kao, PJ Lou - Head & Neck, 2019 - search.ebscohost.com
Abstract Background: Immune checkpoint inhibitors (ICIs) can reinvigorate T cells and
activate the immune system to eliminate cancer cells. Head and neck squamous cell …